Immatics (IMTX) Change in Receivables (2019 - 2025)
Immatics' (IMTX) quarterly Change in Receivables came in at -$5.3 million in Q4 2025, down 870.14% year-on-year from $688175.4 in Q4 2024, and down 254.73% quarter-over-quarter from -$1.5 million in Q3 2025.
Immatics (IMTX) Change in Receivables (2019 - 2025) Analysis & Trends
Immatics has disclosed Change in Receivables across 7 years of filings, most recently posting -$5.3 million for Q4 2025.
- Change in Receivables for Q4 2025 came in at -$5.3 million, down 870.14% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.1 million (down 1017.67% YoY), and the FY2025 annual result was -$6.9 million, down 988.29% from the prior year.
- Change in Receivables came in at -$5.3 million for Q4 2025 at Immatics, down from -$1.5 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.5 million in Q1 2021 to a low of -$5.3 million in Q4 2025.
- The 5-year median for Change in Receivables is -$189926.9 (2022), against an average of -$464930.0.
- Peak annual rise in Change in Receivables reached 1479.64% in 2023, while the deepest fall reached 13576.12% in 2023.
- Immatics' Change in Receivables stood at $50334.7 in 2021, then slumped by 43.25% to $28566.9 in 2022, then slumped by 13576.12% to -$3.8 million in 2023, then jumped by 117.88% to $688175.4 in 2024, then plunged by 870.14% to -$5.3 million in 2025.
- The last three Change in Receivables figures came in at -$5.3 million (Q4 2025), -$1.5 million (Q3 2025), and -$211676.5 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.30 Mn |
| Dec 31, 2025 | -5.30 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -211,676.46 |
| Jun 30, 2025 | -211,676.46 |
| Mar 31, 2025 | -94,669.60 |
| Mar 31, 2025 | -94,669.60 |
| Dec 31, 2024 | 688,175.44 |
| Dec 31, 2024 | 688,175.44 |
| Sep 30, 2024 | -750,083.92 |
| Sep 30, 2024 | -750,083.92 |
| Jun 30, 2024 | -396,294.63 |
| Jun 30, 2024 | -396,294.63 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Sep 30, 2023 | -201,389.24 |
| Sep 30, 2023 | -201,389.24 |